ArticleCancers2022

Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL).

Patrizia Ciammella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.